This trial will study whether non-narcotic pain medications are effective in controlling pain for patients undergoing Bariatric Surgery at UC Davis Medical Center.
- Bariatric Surgery Candidates
- Morbid Obesity
2 Primary · 0 Secondary · Reporting Duration: 3 Days and 14 Days Post Surgery
2 Treatment Groups
Standard of Care
1 of 2
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: Dilaudid Injectable Product · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 35 - 65 · Female Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has Dilaudid Injectable Product been given the green light by the FDA?
"Dilaudid Injectable Product has been approved, so our team assigned it a safety score of 3." - Anonymous Online Contributor
Would I be eligible to participate in this trial?
"In order to be admitted into this clinical trial, applicants must possess obesity and morbidity along with being within the age bracket of 35-65. Presently, a total of 60 individuals are eligible for participation." - Anonymous Online Contributor
Could you elucidate on what research has already been conducted pertaining to Dilaudid Injectable Product?
"Currently, 265 clinical trials are actively studying the effects of Dilaudid Injectable Product. Of those in progress 60 have reached Phase 3. Boston, Massachusetts is home to many of these studies, but there are 1864 other locations hosting this medical research around the world." - Anonymous Online Contributor
For what ailment is Dilaudid Injectable Product often prescribed?
"Synovitis is typically managed with Dilaudid Injectable Product, which can also be employed to tackle ailments such as whiplash syndrome, anxiety, and ophthalmia sympathetic." - Anonymous Online Contributor
Are individuals younger than 20 years of age eligible for this experiment?
"The minimum age requirement for this trial is 35 years old and the maximum permissible age of participants is 65." - Anonymous Online Contributor
Is recruitment for this experiment still open?
"According to the clinicaltrials.gov database, enrollment is currently open for this study which was initially published on January 20th 2021 and underwent its most recent update at 11 March 2022." - Anonymous Online Contributor
How many individuals are engaged with this trial?
"Affirmative. According to clinicaltrials.gov, this medical study is actively accepting participants since its posting on January 20th 2021 and the most recent update was done in March 11th 2022; it requires 60 individuals from a single site." - Anonymous Online Contributor